AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Avanos Medical Inc (NYSE:AVNS)
14.46 USD
-0.010 0.069%Sponsored Reports
Loading...
| Previous Close (in USD) | 14.47 |
|---|---|
| Change | -0.010 0.069% |
| 52 W H/L (in USD) | 25.360/17.390 |
| EBITDA (in USD) | 102.2M |
| PE Ratio | 39.77 |
| Volume | 333549 |
| Diluted Eps TTM | 0.47 |
| Total Assets (in USD) | 1692.4M |
|---|---|
| Total Liabilities (in USD) | 456.1M |
| Revenue TTM (in USD) | 681.5M |
| Cash (in USD) | 87.7M |
| Market Cap (in USD) | 858.936 M |
| Revenue Per Share TTM | 14.791 |
| Gross Profit TTM (in USD) | 450M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Employees: 3771
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Joseph F. Woody | CEO & Director | 1966 |
| 2. | Mr. Michael C. Greiner | Sr. VP, CFO & Principal Accounting Officer | 1973 |
| 3. | Mr. David Edward Ball | Sr. VP of Global Supply Chain & Procurement | 1959 |
| 4. | Mr. William David Haydon | Sr. VP & GM of Pain Management | 1967 |
| 5. | Mr. Kerr W. Holbrook | Sr. VP & GM of Chronic Care | 1967 |
| 6. | Mr. David Crawford | VP of FP&A and Investor Relations and Treasurer | NA |
| 7. | Ms. Michelle Scharfenberg | Sr. VP and Chief Ethics & Compliance Officer | NA |
| 8. | Ms. Mojirade James | Sr. VP, Gen. Counsel & Corp. Sec. | 1967 |
| 9. | Mr. Scott Galovan | VP of Strategy & Corp. Devel. | NA |
| 10. | Mr. Arjun Ranjan Sarker | Sr. VP of International | 1966 |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
-3.180 2.448% | 125 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
|
SYK
Stryker Corporation |
+5.870 1.614% | 364.58 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+0.740 0.802% | 92.31 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+1.790 1.877% | 96.07 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 65.2M | 5.8M | -60.5M | -64M | -18.1M |
| Minority Interest | - | - | - | - | - |
| Net Income | 50.5M | 5.2M | -27.2M | -45.9M | 57.5M |
| Selling General Administrative | 341.9M | 300.3M | 332.6M | 399.1M | 340.4M |
| Gross Profit | 450M | 364.3M | 373.3M | 402.2M | 390.9M |
| Reconciled Depreciation | 47.7M | 38.3M | 42.9M | 36.9M | 33.5M |
| Ebit | 74M | 8.9M | -46.1M | -55.7M | 8.3M |
| Ebitda | 122.9M | 47.4M | -2M | -12.1M | 41.8M |
| Depreciation And Amortization | 48.9M | 38.5M | 44.1M | 43.6M | 33.5M |
| Operating Income | 74M | 8.9M | -46.1M | -55.7M | 0.5M |
| Other Operating Expenses | 746M | 735.7M | 760.9M | 753.3M | 651.8M |
| Interest Expense | 10M | 3.3M | 15.6M | 15M | 26.4M |
| Tax Provision | 14.7M | 0.6M | -33.3M | -18.1M | -9.6M |
| Interest Income | 1.2M | 0.2M | 1.2M | 6.7M | 7.8M |
| Net Interest Income | -8.8M | -3.1M | -14.4M | -8.3M | -18.6M |
| Income Tax Expense | 14.7M | 0.6M | -33.3M | -18.1M | -9.6M |
| Total Revenue | 820M | 744.6M | 714.8M | 697.6M | 652.3M |
| Total Operating Expenses | 376M | 355.4M | 419.4M | 457.9M | 390.4M |
| Cost Of Revenue | 370M | 380.3M | 341.5M | 295.4M | 261.4M |
| Total Other Income Expense Net | -8.8M | -3.1M | -14.4M | -8.3M | -18.6M |
| Net Income From Continuing Ops | 50.5M | 5.2M | -27.2M | -82.1M | -27.7M |
| Net Income Applicable To Common Shares | 50.5M | 5.2M | -27.2M | -45.9M | 57.5M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 1692.4M | 1786.9M | 1594.6M | 1672.8M | 1799.6M |
| Intangible Assets | 239.5M | 251M | 141.2M | 157.7M | 184.3M |
| Other Current Assets | 93.3M | 13.9M | 18.6M | 18.9M | 23.5M |
| Total Liab | 456.1M | 495.7M | 330.7M | 416.3M | 534.4M |
| Total Stockholder Equity | 1236.3M | 1291.2M | 1263.9M | 1256.5M | 1265.2M |
| Other Current Liab | 127.4M | 98.9M | 68.1M | 83.2M | 114.8M |
| Common Stock | 0.5M | 0.5M | 0.5M | 0.5M | 0.5M |
| Capital Stock | 0.5M | 0.5M | 0.5M | 0.5M | 0.5M |
| Retained Earnings | -314.9M | -253.1M | -310.3M | -315.5M | -288.3M |
| Good Will | 796.1M | 819.4M | 801.6M | 802.5M | 800.9M |
| Other Assets | - | 22.2M | 26.5M | 71M | 27.4M |
| Cash | 87.7M | 127.7M | 118.5M | 111.5M | 205.3M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 234.6M | 185.8M | 139.2M | 166.3M | 212.5M |
| Current Deferred Revenue | - | - | - | - | - |
| Net Debt | 121.4M | 152.3M | 69M | 137.3M | 120.1M |
| Short Term Debt | 34.2M | 19M | 14.7M | 15.5M | 14.7M |
| Short Long Term Debt | 8.6M | 6.2M | - | - | - |
| Short Long Term Debt Total | 209.1M | 280M | 187.5M | 248.8M | 325.4M |
| Other Stockholder Equity | 1577.7M | 1579.6M | 1607.5M | 1599.6M | 1585M |
| Property Plant Equipment | - | 163.9M | 168.1M | 175.3M | 184.5M |
| Total Current Assets | 487M | 499.8M | 418.6M | 467.2M | 538.5M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 142.8M | 167.9M | 131.2M | 167.9M | 163.8M |
| Long Term Debt | 159.4M | 226.3M | 130M | 180M | 248.1M |
| Inventory | 163.2M | 190.3M | 150.3M | 168.9M | 145.9M |
| Accounts Payable | 56.3M | 67.9M | 56.4M | 67.6M | 83M |
| Accumulated Other Comprehensive Income | -27M | -35.8M | -33.8M | -28.1M | -32M |
| Non Currrent Assets Other | 19.3M | 17.6M | 16.5M | 11.8M | 11.3M |
| Non Current Assets Total | 1205.4M | 1287.1M | 1176M | 1205.6M | 1261.1M |
| Capital Lease Obligations | 41.1M | 47.5M | 57.5M | 68.8M | 77.3M |
| Long Term Debt Total | - | 226.3M | 130M | 180M | 248.1M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -135.4M | -21M | -4M | -108.1M | 639.5M |
| Total Cashflows From Investing Activities | -135.4M | -21M | -24.2M | -108.1M | 639.5M |
| Total Cash From Financing Activities | 56.7M | -55.3M | -70M | 1.5M | -324.4M |
| Net Income | 50.5M | 5.2M | -27.2M | -45.9M | 57.5M |
| Change In Cash | 9.2M | 7M | -93.8M | -179.2M | 164.8M |
| Begin Period Cash Flow | 118.5M | 111.5M | 205.3M | 384.5M | 219.7M |
| End Period Cash Flow | 127.7M | 118.5M | 111.5M | 205.3M | 384.5M |
| Total Cash From Operating Activities | 90.9M | 87.3M | -2.5M | -74.5M | -145.6M |
| Depreciation | 47.7M | 38.3M | 42.9M | 36.9M | 33.5M |
| Other Cashflows From Investing Activities | -116.1M | - | - | -57.5M | 65.7M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -30.9M | 17.2M | -21.8M | -21.3M | -34.5M |
| Sale Purchase Of Stock | -45.5M | -11.5M | -0.9M | -3.6M | -0.9M |
| Other Cashflows From Financing Activities | 398.8M | 26.2M | 185.7M | 5.3M | 15.5M |
| Capital Expenditures | 19.3M | 21M | 20.2M | 50.6M | 49.1M |
| Change In Working Capital | -24.3M | 26M | -67.8M | -59.6M | -143.4M |
| Other Non Cash Items | 1.1M | 8M | 11.6M | -9.9M | -107.4M |
| Free Cash Flow | 71.6M | 66.3M | -22.7M | -125.1M | -194.7M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | iShares Core S&P Small-Cap ETF | 3 months ago | 2964513 |
| 2. | Vanguard Total Stock Mkt Idx Inv | 4 months ago | 1455382 |
| 3. | T. Rowe Price Small-Cap Value | 4 months ago | 1413094 |
| 4. | iShares Russell 2000 ETF | 3 months ago | 1247266 |
| 5. | Vanguard Small Cap Index | 4 months ago | 1154106 |
| 6. | Brown Advisory Small-Cap Fdmtl Val Inv | 4 months ago | 1017974 |
| 7. | Paradice Global Small Mid Cap Strategy | 5 months ago | 801124 |
| 8. | Vanguard Small Cap Value Index Inv | 4 months ago | 778556 |
| 9. | T. Rowe Price U.S. SC Value Eq Tr-Z | 5 months ago | 741473 |
| 10. | Westwood Mgt SmallCap Value | 5 months ago | 709156 |
| 11. | Westwood Quality SmallCap Fund Inst | 5 months ago | 709156 |
| 12. | Vanguard Institutional Extnd Mkt Idx Tr | 4 months ago | 678701 |
| 13. | DFA US Small Cap Value I | 4 months ago | 662533 |
| 14. | Tributary Small Cap Equity | 4 months ago | 574786 |
| 15. | William Blair Small Cap Value I | 4 months ago | 522799 |
| 16. | iShares S&P Small-Cap 600 Value ETF | 3 months ago | 469145 |
| 17. | Fidelity Small Cap Index | 5 months ago | 462375 |
| 18. | iShares Russell 2000 Value ETF | 3 months ago | 444913 |
| 19. | SPDR® Portfolio S&P 600™ Sm Cap ETF | 3 months ago | 421237 |
| 20. | Tributary Small Company Instl | 5 months ago | 376330 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 8 months ago | 7011219 |
| 2. | Vanguard Group Inc | 5 months ago | 5320302 |
| 3. | RGM Capital LLC | 5 months ago | 3171455 |
| 4. | Dimensional Fund Advisors, Inc. | 5 months ago | 2589985 |
| 5. | T. Rowe Price Investment Management,Inc. | 5 months ago | 2367045 |
| 6. | Westwood Holdings Group Inc | 5 months ago | 1991055 |
| 7. | State Street Corp | 5 months ago | 1821884 |
| 8. | Brown Advisory Holdings Inc | 5 months ago | 1700876 |
| 9. | William Blair Investment Management, LLC | 5 months ago | 1377602 |
| 10. | Paradice Investment Management LLC | 5 months ago | 1262249 |
| 11. | Morgan Stanley - Brokerage Accounts | 5 months ago | 1132447 |
| 12. | Neuberger Berman Group LLC | 5 months ago | 1066814 |
| 13. | Geode Capital Management, LLC | 5 months ago | 1054162 |
| 14. | Tributary Capital Management, LLC | 5 months ago | 646629 |
| 15. | Prudential Financial Inc | 5 months ago | 586730 |
| 16. | Royal Bank of Canada | 5 months ago | 580554 |
| 17. | Charles Schwab Investment Management Inc | 5 months ago | 523494 |
| 18. | Northern Trust Corp | 5 months ago | 502043 |
| 19. | Arrowstreet Capital Limited Partnership | 5 months ago | 454931 |
| 20. | Goldman Sachs Group Inc | 5 months ago | 418417 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
